Reports Q2 revenue $2.73B, consensus $2.61B. “We are very pleased to report another quarter of strong revenue and earnings growth across both segments,” said Jon Rousseau, CEO. “Our Pharmacy Solutions business delivered impressive growth, while our Provider Services business saw margin expansion and revenue growth afforded by our operational excellence, scale, and efficiencies. We remain very confident in our ability execute on driving the most compassionate, low-cost, and efficient care right to our patients, and believe that BrightSpring remains in a great position for the remainder of the year and as we enter 2025.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTSG:
- Is BTSG a Buy, Before Earnings?
- BrightSpring Health Services Earns Multiple Accreditations Across the Country for Quality Care
- BrightSpring Health Services, Inc. to Announce Second Quarter 2024 Financial Results on August 2, 2024
- BrightSpring Health Services Announces Definitive Agreement to Acquire Haven, Expanding Its Hospice Services into the CON State of Florida
- BrightSpring Health to acquire Haven Hospice for $60M